KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $23.5 billion.

  • Zimmer Biomet Holdings' Liabilities and Shareholders Equity rose 813.85% to $23.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $89.9 billion, marking a year-over-year increase of 430.76%. This contributed to the annual value of $21.4 billion for FY2024, which is 61.22% down from last year.
  • As of Q3 2025, Zimmer Biomet Holdings' Liabilities and Shareholders Equity stood at $23.5 billion, which was up 813.85% from $22.9 billion recorded in Q2 2025.
  • In the past 5 years, Zimmer Biomet Holdings' Liabilities and Shareholders Equity ranged from a high of $24.2 billion in Q2 2021 and a low of $21.1 billion during Q4 2022
  • Over the past 5 years, Zimmer Biomet Holdings' median Liabilities and Shareholders Equity value was $21.5 billion (recorded in 2024), while the average stood at $22.2 billion.
  • As far as peak fluctuations go, Zimmer Biomet Holdings' Liabilities and Shareholders Equity plummeted by 1143.74% in 2022, and later soared by 813.85% in 2025.
  • Over the past 5 years, Zimmer Biomet Holdings' Liabilities and Shareholders Equity (Quarter) stood at $23.5 billion in 2021, then decreased by 10.19% to $21.1 billion in 2022, then grew by 2.05% to $21.5 billion in 2023, then fell by 0.61% to $21.4 billion in 2024, then rose by 9.94% to $23.5 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $23.5 billion for Q3 2025, versus $22.9 billion for Q2 2025 and $22.2 billion for Q1 2025.